Cargando…

ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study

After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by t...

Descripción completa

Detalles Bibliográficos
Autores principales: Domènech-Montoliu, Salvador, Puig-Barberà, Joan, Pac-Sa, Maria Rosario, Vidal-Utrillas, Paula, Latorre-Poveda, Marta, Rio-González, Alba Del, Ferrando-Rubert, Sara, Ferrer-Abad, Gema, Sánchez-Urbano, Manuel, Aparisi-Esteve, Laura, Badenes-Marques, Gema, Cervera-Ferrer, Belén, Clerig-Arnau, Ursula, Dols-Bernad, Claudia, Fontal-Carcel, Maria, Gomez-Lanas, Lorna, Jovani-Sales, David, León-Domingo, Maria Carmen, Llopico-Vilanova, Maria Dolores, Moros-Blasco, Mercedes, Notari-Rodríguez, Cristina, Ruíz-Puig, Raquel, Valls-López, Sonia, Arnedo-Pena, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507737/
https://www.ncbi.nlm.nih.gov/pubmed/34639344
http://dx.doi.org/10.3390/ijerph181910039
_version_ 1784581925845860352
author Domènech-Montoliu, Salvador
Puig-Barberà, Joan
Pac-Sa, Maria Rosario
Vidal-Utrillas, Paula
Latorre-Poveda, Marta
Rio-González, Alba Del
Ferrando-Rubert, Sara
Ferrer-Abad, Gema
Sánchez-Urbano, Manuel
Aparisi-Esteve, Laura
Badenes-Marques, Gema
Cervera-Ferrer, Belén
Clerig-Arnau, Ursula
Dols-Bernad, Claudia
Fontal-Carcel, Maria
Gomez-Lanas, Lorna
Jovani-Sales, David
León-Domingo, Maria Carmen
Llopico-Vilanova, Maria Dolores
Moros-Blasco, Mercedes
Notari-Rodríguez, Cristina
Ruíz-Puig, Raquel
Valls-López, Sonia
Arnedo-Pena, Alberto
author_facet Domènech-Montoliu, Salvador
Puig-Barberà, Joan
Pac-Sa, Maria Rosario
Vidal-Utrillas, Paula
Latorre-Poveda, Marta
Rio-González, Alba Del
Ferrando-Rubert, Sara
Ferrer-Abad, Gema
Sánchez-Urbano, Manuel
Aparisi-Esteve, Laura
Badenes-Marques, Gema
Cervera-Ferrer, Belén
Clerig-Arnau, Ursula
Dols-Bernad, Claudia
Fontal-Carcel, Maria
Gomez-Lanas, Lorna
Jovani-Sales, David
León-Domingo, Maria Carmen
Llopico-Vilanova, Maria Dolores
Moros-Blasco, Mercedes
Notari-Rodríguez, Cristina
Ruíz-Puig, Raquel
Valls-López, Sonia
Arnedo-Pena, Alberto
author_sort Domènech-Montoliu, Salvador
collection PubMed
description After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castelló and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 ± 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24–2.27), and symptoms of fatigue (1.79, 95% CI 1.08–2.95), myalgia (2.06, 95% CI 1.10–3.84), headache (2.61, 95% CI 1.58–4.31), and disorder of vision (4.26 95% CI 1.33–13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results.
format Online
Article
Text
id pubmed-8507737
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-85077372021-10-13 ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study Domènech-Montoliu, Salvador Puig-Barberà, Joan Pac-Sa, Maria Rosario Vidal-Utrillas, Paula Latorre-Poveda, Marta Rio-González, Alba Del Ferrando-Rubert, Sara Ferrer-Abad, Gema Sánchez-Urbano, Manuel Aparisi-Esteve, Laura Badenes-Marques, Gema Cervera-Ferrer, Belén Clerig-Arnau, Ursula Dols-Bernad, Claudia Fontal-Carcel, Maria Gomez-Lanas, Lorna Jovani-Sales, David León-Domingo, Maria Carmen Llopico-Vilanova, Maria Dolores Moros-Blasco, Mercedes Notari-Rodríguez, Cristina Ruíz-Puig, Raquel Valls-López, Sonia Arnedo-Pena, Alberto Int J Environ Res Public Health Article After a COVID-19 outbreak in the Falles festival of Borriana (Spain) during March 2020, a cohort of patients were followed until October 2020 to estimate complications post-COVID-19, considering ABO blood groups (ABO). From 536 laboratory-confirmed cases, 483 completed the study (90.1%) carried by the Public Health Center of Castelló and the Emergency and Microbiology and Clinical Analysis of Hospital de la Plana Vila-real. The study included ABO determination and telephone interviews of patients. The participants had a mean age of 37.2 ± 17.1 years, 300 females (62.1%). ABO were O (41.4%), A (45.5%), B (9.1%), and AB (3.9%). We found no difference in the incidence of COVID-19 infections. A total of 159 (32.9%) patients reported one or more post-COVID-19 complications with divergent incidences after adjustment: O (32.3%), A (32.6%), B (54.1%), and AB (27.6%); B groups had more complications post-COVID-19 when compared with O group (adjusted relative risk [aRR] 95% confidence interval [CI] 1.68, 95% CI 1.24–2.27), and symptoms of fatigue (1.79, 95% CI 1.08–2.95), myalgia (2.06, 95% CI 1.10–3.84), headache (2.61, 95% CI 1.58–4.31), and disorder of vision (4.26 95% CI 1.33–13.60). In conclusion, we observed significant differences in post-COVID-19 complications by ABO, with a higher incidence in B group. Additional research is justified to confirm our results. MDPI 2021-09-24 /pmc/articles/PMC8507737/ /pubmed/34639344 http://dx.doi.org/10.3390/ijerph181910039 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Domènech-Montoliu, Salvador
Puig-Barberà, Joan
Pac-Sa, Maria Rosario
Vidal-Utrillas, Paula
Latorre-Poveda, Marta
Rio-González, Alba Del
Ferrando-Rubert, Sara
Ferrer-Abad, Gema
Sánchez-Urbano, Manuel
Aparisi-Esteve, Laura
Badenes-Marques, Gema
Cervera-Ferrer, Belén
Clerig-Arnau, Ursula
Dols-Bernad, Claudia
Fontal-Carcel, Maria
Gomez-Lanas, Lorna
Jovani-Sales, David
León-Domingo, Maria Carmen
Llopico-Vilanova, Maria Dolores
Moros-Blasco, Mercedes
Notari-Rodríguez, Cristina
Ruíz-Puig, Raquel
Valls-López, Sonia
Arnedo-Pena, Alberto
ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_full ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_fullStr ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_full_unstemmed ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_short ABO Blood Groups and the Incidence of Complications in COVID-19 Patients: A Population-Based Prospective Cohort Study
title_sort abo blood groups and the incidence of complications in covid-19 patients: a population-based prospective cohort study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8507737/
https://www.ncbi.nlm.nih.gov/pubmed/34639344
http://dx.doi.org/10.3390/ijerph181910039
work_keys_str_mv AT domenechmontoliusalvador abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT puigbarberajoan abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT pacsamariarosario abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT vidalutrillaspaula abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT latorrepovedamarta abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT riogonzalezalbadel abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT ferrandorubertsara abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT ferrerabadgema abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT sanchezurbanomanuel abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT aparisiestevelaura abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT badenesmarquesgema abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT cerveraferrerbelen abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT clerigarnauursula abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT dolsbernadclaudia abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT fontalcarcelmaria abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT gomezlanaslorna abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT jovanisalesdavid abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT leondomingomariacarmen abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT llopicovilanovamariadolores abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT morosblascomercedes abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT notarirodriguezcristina abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT ruizpuigraquel abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT vallslopezsonia abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy
AT arnedopenaalberto abobloodgroupsandtheincidenceofcomplicationsincovid19patientsapopulationbasedprospectivecohortstudy